Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
26.44
+0.36 (1.38%)
Oct 24, 2024, 4:00 PM EDT - Market closed
Denali Therapeutics Market Cap
Denali Therapeutics has a market cap or net worth of $3.79 billion as of October 24, 2024. Its market cap has increased by 27.23% in one year.
Market Cap
3.79B
Enterprise Value
2.44B
1-Year Change
27.23%
Ranking
Category
Stock Price
$26.44
Market Cap Chart
Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $3.79B, an increase of 100.58%. That is a compound annual growth rate of 10.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2024 | 3.73B | 25.90% |
| Dec 29, 2023 | 2.97B | -21.48% |
| Dec 30, 2022 | 3.78B | -30.66% |
| Dec 31, 2021 | 5.45B | -45.77% |
| Dec 31, 2020 | 10.04B | 500.42% |
| Dec 31, 2019 | 1.67B | -14.73% |
| Dec 31, 2018 | 1.96B | 42.57% |
| Dec 29, 2017 | 1.38B | -27.09% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oscar Health | 4.10B |
| TransMedics Group | 4.01B |
| Surgery Partners | 3.96B |
| Alvotech | 3.89B |
| Haemonetics | 3.84B |
| ADMA Biologics | 3.70B |
| Merus | 3.60B |
| Axonics | 3.59B |